Mogamulizumab and Nadolol and Bendroflumethiazide
Determining the interaction of Mogamulizumab and Nadolol and Bendroflumethiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
Generic Name: bendroflumethiazide / nadolol
Brand name: Corzide 40/5, Corzide 80/5, Corzide
Synonyms: Bendroflumethiazide and nadolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-Nadopen V 200
- Mogamulizumab-Nadopen V 400
- Mogamulizumab-Nadostine
- Mogamulizumab-Nadostine Sucrose-Free
- Mogamulizumab-Nafcil
- Mogamulizumab-Nafcillin
- Nadolol and Bendroflumethiazide-Mogamulizumab-kpkc
- Nadolol and Bendroflumethiazide-Mogamulizumab-kpkc Intravenous
- Nadolol and Bendroflumethiazide-Molindone
- Nadolol and Bendroflumethiazide-Mometasone (Oral Inhalation)
- Nadolol and Bendroflumethiazide-Mometasone and Formoterol
- Nadolol and Bendroflumethiazide-Mometasone and formoterol Inhalation